• You know it’s a quiet morning in the marketplace when the #1 most read story this morning deals with the fact that Cathie Wood sold a whopping 2,000 shares of Nvidia (NVDA) late last week.  However, there are plenty of reasons to think that we’ll see plenty activity as the week goes on. 
  • The XLV healthcare ETF has broken out in a very important sideways range in recent weeks.  We’d also not that one of its subgroups…the biotechs…are testing a KEY resistance level.  If the IBB biotech ETF can break above this level in any meaningful way, it’s going to be very bullish for this group on a technical basis. 


You don't have access to this post on The Maley Report at the moment, but if you upgrade your account you'll be able to see the whole thing, as well as all the other posts in the archive! Subscribing only takes a few seconds and will give you immediate access.

This post is for subscribers on the Before the Open and All-Access tiers only

Try 14 Days Free